Cargando…

4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR)—A Novel Oncometabolite Modulating Cancer-Endothelial Interactions in Breast Cancer Metastasis

The accumulation of specific metabolic intermediates is known to promote cancer progression. We analyzed the role of 4-pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR), a nucleotide metabolite that accumulates in the blood of cancer patients, using the 4T1 murine in vivo breast cancer model, and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koszalka, Patrycja, Kutryb-Zajac, Barbara, Mierzejewska, Paulina, Tomczyk, Marta, Wietrzyk, Joanna, Serafin, Pawel K., Smolenski, Ryszard T., Slominska, Ewa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145394/ https://www.ncbi.nlm.nih.gov/pubmed/35628582 http://dx.doi.org/10.3390/ijms23105774

Ejemplares similares

An unusual nicotinamide derivative, 4-pyridone-3-carboxamide ribonucleoside (4PYR), is a novel endothelial toxin and oncometabolite
por: Mierzejewska, Paulina, et al.
Publicado: (2021)

Differences in Extracellular NAD(+) and NMN Metabolism on the Surface of Vascular Endothelial Cells
por: Jablonska, Patrycja, et al.
Publicado: (2022)

4-Pyridone-3-carboxamide-1-β-D-ribonucleoside Triphosphate (4PyTP), a Novel NAD(+) Metabolite Accumulating in Erythrocytes of Uremic Children: A Biomarker for a Toxic NAD(+) Analogue in Other Tissues?
por: Synesiou, Elena, et al.
Publicado: (2011)

Impaired l-arginine metabolism marks endothelial dysfunction in CD73-deficient mice
por: Mierzejewska, P., et al.
Publicado: (2019)

Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor‐dependent mechanisms
por: Kutryb‐Zajac, Barbara, et al.
Publicado: (2018)

Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases
por: Kutryb-Zajac, Barbara, et al.
Publicado: (2020)

Macrophage-Derived Adenosine Deaminase 2 Correlates with M2 Macrophage Phenotype in Triple Negative Breast Cancer
por: Kutryb-Zajac, Barbara, et al.
Publicado: (2021)

The new insight into extracellular NAD(+) degradation‐the contribution of CD38 and CD73 in calcific aortic valve disease
por: Jablonska, Patrycja, et al.
Publicado: (2021)

Cardiac Mitochondria Dysfunction in Dyslipidemic Mice
por: Braczko, Alicja, et al.
Publicado: (2022)

Endothelial Effects of Simultaneous Expression of Human HO-1, E5NT, and ENTPD1 in a Mouse
por: Mierzejewska, Paulina, et al.
Publicado: (2023)

5-Aminoimidazole-4-carboxamide ribonucleoside-induced autophagy flux during differentiation of monocytic leukemia cells
por: Dembitz, Vilma, et al.
Publicado: (2017)

CoCl(2)-Mimicked Endothelial Cell Hypoxia Induces Nucleotide Depletion and Functional Impairment That Is Reversed by Nucleotide Precursors
por: Kutryb-Zajac, Barbara, et al.
Publicado: (2022)

5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts
por: Dembitz, Vilma, et al.
Publicado: (2020)

The effect of 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) on fatty acid oxidation in hepatocytes isolated from neonatal piglets
por: Xi, Lin, et al.
Publicado: (2012)

Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington’s Disease
por: Tomczyk, Marta, et al.
Publicado: (2022)

Nucleotide ecto-enzyme metabolic pattern and spatial distribution in calcific aortic valve disease; its relation to pathological changes and clinical presentation
por: Kutryb-Zajac, Barbara, et al.
Publicado: (2019)

The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells
por: Kim, Won Gu, et al.
Publicado: (2014)

Novel Targets for a Combination of Mechanical Unloading with Pharmacotherapy in Advanced Heart Failure
por: Jedrzejewska, Agata, et al.
Publicado: (2022)

Synthesis of 4-Pyridone-3-sulfate and an improved synthesis of 3-Hydroxy-4-Pyridone
por: Behrman, Edward J
Publicado: (2009)

High Throughput Procedure for Comparative Analysis of In Vivo Cardiac Glucose or Amino Acids Use in Cardiovascular Pathologies and Pharmacological Treatments
por: Tomczyk, Marta, et al.
Publicado: (2021)

Kynurenine: an oncometabolite in colon cancer
por: Venkateswaran, Niranjan, et al.
Publicado: (2020)

Purine Nucleotides Metabolism and Signaling in Huntington’s Disease: Search for a Target for Novel Therapies
por: Tomczyk, Marta, et al.
Publicado: (2021)

Effect of Deer Antler Extract on Muscle Differentiation and 5-Aminoimidazole-4-Carboxamide Ribonucleoside (AICAR)-Induced Muscle Atrophy in C2C12 Cells
por: Jo, Kyungae, et al.
Publicado: (2021)

Oncometabolites and the response to radiotherapy
por: Xiang, Kexu, et al.
Publicado: (2020)

Naturally occurring modified ribonucleosides
por: McCown, Phillip J., et al.
Publicado: (2020)

Oncometabolites as biomarkers in thyroid cancer: a systematic review
por: Khatami, Fatemeh, et al.
Publicado: (2019)

N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin
por: Lenglet, Aurélie, et al.
Publicado: (2016)

The emerging role of fumarate as an oncometabolite
por: Yang, Ming, et al.
Publicado: (2012)

Oncometabolites: tailoring our genes
por: Nowicki, Stefan, et al.
Publicado: (2015)

Metabolic Rewiring and the Characterization of Oncometabolites
por: Beyoğlu, Diren, et al.
Publicado: (2021)

Crystal structure of 2,6-dimethyl-4-pyridone hemihydrate
por: Nguyen, Dalena M., et al.
Publicado: (2015)

Urinary Excretion of N(1)-Methylnicotinamide and N(1)-Methyl-2-Pyridone-5-Carboxamide and Mortality in Kidney Transplant Recipients
por: Deen, Carolien P.J., et al.
Publicado: (2020)

Urinary Excretion of N(1)-methyl-2-pyridone-5-carboxamide and N(1)-methylnicotinamide in Renal Transplant Recipients and Donors
por: Deen, Carolien P. J., et al.
Publicado: (2020)

Oncometabolites—A Link between Cancer Cells and Tumor Microenvironment
por: Baryła, Maksymilian, et al.
Publicado: (2022)

Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies
por: Nadhan, Revathy, et al.
Publicado: (2023)

Nucleotide Catabolism on the Surface of Aortic Valve Xenografts; Effects of Different Decellularization Strategies
por: Kutryb-Zajac, Barbara, et al.
Publicado: (2016)

Structural basis of reiterative transcription from the pyrG and pyrBI promoters by bacterial RNA polymerase
por: Shin, Yeonoh, et al.
Publicado: (2020)

Enhanced Muscle Strength in Dyslipidemic Mice and Its Relation to Increased Capacity for Fatty Acid Oxidation
por: Tomczyk, Marta, et al.
Publicado: (2021)

A chemoproteomic portrait of the oncometabolite fumarate
por: Kulkarni, Rhushikesh A., et al.
Publicado: (2019)

Oncometabolites: A new insight for oncology
por: Khatami, Fatemeh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_56a9kjrsjdi6d4mnprbonf9t9t